Back
Mersana Therapeutics Quote, Financials, Valuation and Earnings
Sell
18
MRSN
Mersana Therapeutics
Last Price:
2.57
Seasonality Move:
-4.06%
7 Day Trial
ALL ACCESS PASS
$
7
Mersana Therapeutics Price Quote
$2.57
-0.04 (-1.53%)
(Updated: May 15, 2024 at 6:55 PM ET)
Mersana Therapeutics Key Stats
Sell
18
Mersana Therapeutics (MRSN)
is a Sell
Day range:
$2.45 - $2.72
52-week range:
$0.80 - $9.62
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.15
P/B ratio:
11.41%
Volume:
5.1M
Avg. volume:
1.8M
1-year change:
-67.5%
Market cap:
$319.4M
Revenue:
$36.9M
EPS:
$-1.14
How Much Does Mersana Therapeutics Make?
-
How Much Are Mersana Therapeutics's Sales Annually?
MRSN Revenues are $36.9M -
How Much Profit Does Mersana Therapeutics's Make A Year?
MRSN net income is -$171.7M
Is Mersana Therapeutics Growing As A Company?
-
What Is Mersana Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.18% -
What Is Mersana Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Mersana Therapeutics Stock Price Performance
-
Did Mersana Therapeutics Stock Go Up Last Month?
Mersana Therapeutics share price went down by -31.5% last month -
Did MRSN's Share Price Rise Over The Last Year?
MRSN share price fell by -67.5% over the past 1 year
What Is Mersana Therapeutics 52-Week High & Low?
-
What Is Mersana Therapeutics’s 52-Week High Share Price?
Mersana Therapeutics has traded as high as $9.62 over the past 52 weeks -
What Is Mersana Therapeutics’s 52-Week Low Share Price?
Mersana Therapeutics has traded as low as $0.80 over the past 52 weeks
Mersana Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Mersana Therapeutics?
-
How Much Debt Does Mersana Therapeutics Have?
Total long term debt quarterly is $25.3M -
How Much Cash Does Mersana Therapeutics Have?
Cash and short term investments quarterly total is $183.1M -
What Is Mersana Therapeutics’s Book Value Per Share?
Book value per share is 0.23
Is Mersana Therapeutics Cash Flow Positive?
-
What Is MRSN Cash Flow From Operations?
Cash flow from operations (TTM) is -$172.5M -
What Is Mersana Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $79M -
What Is Mersana Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $45.9M
Mersana Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
MRSN return on invested capital is -169.81% -
What Is Mersana Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -52.07% -
What Is MRSN Return On Equity?
ROE is a measure of profitability and is -248.57%
Mersana Therapeutics Earnings Date & Stock Price
-
What Is Mersana Therapeutics's Stock Price Today?
A single share of MRSN can be purchased today for 2.61 -
What Is Mersana Therapeutics’s Stock Symbol?
Mersana Therapeutics trades on the nasdaq under the ticker symbol: MRSN -
When Is Mersana Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Mersana Therapeutics is scheduled on August 9, 2024 -
When Is MRSN's next ex-dividend date?
Mersana Therapeutics's next ex-dividend date is May 16, 2024 -
How To Buy Mersana Therapeutics Stock?
You can buy Mersana Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Mersana Therapeutics Competitors
-
Who Are Mersana Therapeutics's Competitors?
Below is a list of companies who compete with Mersana Therapeutics or are related in some way:
Mersana Therapeutics Dividend Yield
Data Unavailable
Mersana Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 12.97% |
| Revenue: | 18.5% | 11.54% |
Analyst Recommendations
| Buy Recommendations: | 7 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 6.38 |
| Upside from Last Price: | 144.25% |